Diabetes over weight-loss narrative - Unlike the global focus on obesity, Indias opportunity lies primarily in better diabetes management and complication prevention, a far larger clinical and economic burden here
Despite being discovered first, it received less clinical attention for decades because early research suggested that GIP signaling was impaired in type 2 diabetes, making it seem like an unlikely therapeutic target
Semaglutide Program from Peak Medical Its being touted as a game-changer in the world of weight loss drugs because, well, it actually works
Although the exact mechanisms by which the coordinated actions of GLP-1 receptor agonism and NMDA receptor antagonism correct metabolic diseases await further elucidation, the extensive alterations in transcriptomic and proteomic responses within the hypothalamus, linked to glutamatergic signalling and synaptic plasticity, imply that the conjugate might elicit neurostructural changes in GLP-1-receptor-expressing neurons
Same-day onboarding
Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game Summary Diarrhea is a recognized semaglutide side effect, appearing in about 10% of patients in a 2025 Bayesian network meta-analysis and 10.6% in at least one cohort, so this side effect is measurable rather than rare complaints